You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Regulatory Post Marketing Commitment Plan

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gabapen for Pediatric

Completed
Has Results
  • Epilepsies, Partial
  • (no location specified)
Feb 1, 2021

Long-Term Use Of Sildenafil

Completed
Has Results
  • Pulmonary Hypertension
  • (no location specified)
Jan 28, 2021

Amlodipine/Atorvastatin Drug Use Investigation

Completed
Has Results
  • Hypertension
  • +3 more
  • (no location specified)
Jan 26, 2021

Lyrica (Regulatory Post Marketing Commitment Plan)

Completed
Has Results
  • Neuralgia
  • Pregabalin (Lyrica) capsule
  • (no location specified)
Jan 15, 2021

Long Term Use Of Lyrica

Completed
Has Results
  • Neuropathic Pain
  • Pregabalin (Lyrica) capsule
  • (no location specified)
Jan 15, 2021

(Regulatory Post Marketing Commitment Plan)

Completed
Has Results
  • Hypertension
  • (no location specified)
Dec 19, 2020

Pregabalin for Fibromyalgia

Completed
Has Results
  • Pain Associated With Fibromyalgia
  • (no location specified)
Jan 15, 2021

Maraviroc In Patients For HIV Patients

Completed
Has Results
  • CCR5-tropic HIV-1 Infection
  • CELSENTRI® Tablets
  • (no location specified)
Dec 6, 2019

Crizotinib (Regulatory Post Marketing Commitment Plan)

Completed
Has Results
  • Non-small Cell Lung Cancer
  • Crizotinib (Xalkori)
  • (no location specified)
Sep 12, 2019

Korean Regulatory Post Marketing Surveillance for Somavert

Not yet recruiting
  • Acromegaly
  • (no location specified)
Jul 18, 2022

Xolair® for Chronic Rhinosinusitis With Nasal Polyps

Recruiting
  • Chronic Rhinosinusitis With Nasal Polyps
  • Xolair
  • Bundang Gu, Gyeonggi Do, Korea, Republic of
    Novartis Investigative Site
Jan 19, 2023

(rPMS) Study of Rybelsus to Evaluate Safety and Effectiveness in

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • (no location specified)
Jan 27, 2023

(rPMS) Study of Ozempic to Evaluate Safety and Effectiveness in

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • (no location specified)
Jan 17, 2023

'OLAP' (OLAparib Regulatory Post-marketing Surveillance)

Recruiting
  • Ovarian Cancer
  • +3 more
    • Busan, Korea, Republic of
    • +17 more
    Jan 9, 2023

    Lucentis® in Patients With Retinopathy of Prematurity

    Not yet recruiting
    • Retinopathy of Prematurity
    • Lucentis
    • (no location specified)
    Jun 28, 2022

    Diphtheria, Tetanus, Pertussis Trial in Seoul (TETRAXIM™: Combined adsorbed diphtheria, tetanus, acellular pertussis and

    Completed
    Has Results
    • Diphtheria
    • +3 more
    • TETRAXIM™: Combined adsorbed diphtheria, tetanus, acellular pertussis and enhanced inactivated polio
    • Seoul, Korea, Republic of
      (unnamed)
    Mar 15, 2022

    Herpes Zoster Subunit Vaccine During Pregnancy in Adult

    Not yet recruiting
    • Herpes Zoster
    • Data collection
    • (no location specified)
    Mar 31, 2023

    ELIQUIS Regulatory Post-Marketing Surveillance In Clinical

    Completed
    • Venous Thromboembolism
      • Shinjuku-ku, Tokyo, Japan
        Local Institution
      Feb 3, 2022

      Regulatory Post-Marketing Surveillance Study for Brolucizumab

      Recruiting
      • Neovascular Age-related Macular Degeneration
      • brolucizumab
      • Daegu, Dalseo Gu, Korea, Republic of
      • +26 more
      Jun 21, 2022

      Safety And Efficacy Of Rifabutin In HIV Patients

      Completed
      Has Results
      • Non-tuberculous Mycobacterial Diseases
      • +2 more
      • (no location specified)
      Jun 13, 2019

      Vahelva Respimat Regulatory Post-marketing Surveillance in

      Completed
      Has Results
      • Pulmonary Disease, Chronic Obstructive
      • Vahelva® Respimat® (Tiotropium + Olodaterol fixed dose combination)
      • One Or Multiple Sites, Korea, Republic of
        Chonnam National University Hospital
      Feb 28, 2022

      .(Post Marketing Commitment Plan)

      Completed
      Has Results
      • Overactive Bladder
      • Tolterodine tartrate
      • (no location specified)
      Jan 26, 2021

      (PMS) in Korean Patients With Type 2 Diabetes Mellitus

      Recruiting
      • Diabetes Mellitus, Type 2
      • Cheonan-si, Cheonan-si, Chungcheongnam-do, Korea, Republic of
      • +2 more
      Jul 26, 2022

      (rPMS) Study of Xultophy® to Evaluate Safety and Effectiveness

      Enrolling by invitation
      • Diabetes Mellitus, Type 2
      • Xultophy® (insulin degludec/liraglutide)
      • Daejeon, Cheongsa-ro, Seo-gu, Korea, Republic of
      • +9 more
      Mar 21, 2022

      Iclusig PMS in CML or Ph+ALL Patients

      Recruiting
      • Chronic Myeloid Leukemia
      • Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
      • Busan, Korea, Republic of
        Kosin University Gaspel Hospital
      Sep 16, 2021